| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |